4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer

Clinical trial NCT03364348 · COMPLETED

Trial details

NCT number: NCT03364348
Sponsor: George W. Sledge Jr.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HER2 Positive Breast Carcinoma Recurrent Breast Carcinoma Stage III Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer

Start date: 2017-10-30
Primary completion: 2021-02-15
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.